MX2021011314A - Capsulas y recubrimientos de capsulas para formas de dosificacion de residencia gastrica. - Google Patents

Capsulas y recubrimientos de capsulas para formas de dosificacion de residencia gastrica.

Info

Publication number
MX2021011314A
MX2021011314A MX2021011314A MX2021011314A MX2021011314A MX 2021011314 A MX2021011314 A MX 2021011314A MX 2021011314 A MX2021011314 A MX 2021011314A MX 2021011314 A MX2021011314 A MX 2021011314A MX 2021011314 A MX2021011314 A MX 2021011314A
Authority
MX
Mexico
Prior art keywords
gastric residence
dosage forms
gastric
capsule
capsules
Prior art date
Application number
MX2021011314A
Other languages
English (en)
Spanish (es)
Inventor
Erick Peeke
Nupura Bhise
David Altreuter
Marlene Schwarz
Megan Bishoff
Sonia Holar
Original Assignee
Lyndra Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lyndra Therapeutics Inc filed Critical Lyndra Therapeutics Inc
Publication of MX2021011314A publication Critical patent/MX2021011314A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/005Coating of tablets or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
MX2021011314A 2019-03-20 2020-03-19 Capsulas y recubrimientos de capsulas para formas de dosificacion de residencia gastrica. MX2021011314A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962821352P 2019-03-20 2019-03-20
PCT/US2020/023704 WO2020191229A1 (en) 2019-03-20 2020-03-19 Capsules and capsule coatings for gastric residence dosage forms

Publications (1)

Publication Number Publication Date
MX2021011314A true MX2021011314A (es) 2021-12-10

Family

ID=72519175

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2021011314A MX2021011314A (es) 2019-03-20 2020-03-19 Capsulas y recubrimientos de capsulas para formas de dosificacion de residencia gastrica.
MX2025012985A MX2025012985A (es) 2019-03-20 2021-09-17 Capsulas y recubrimientos de capsulas para formas de dosificacion de residencia gastrica

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2025012985A MX2025012985A (es) 2019-03-20 2021-09-17 Capsulas y recubrimientos de capsulas para formas de dosificacion de residencia gastrica

Country Status (10)

Country Link
US (2) US12447130B2 (enExample)
EP (1) EP3941445A4 (enExample)
JP (2) JP2022525926A (enExample)
CN (2) CN119033720A (enExample)
AU (1) AU2020240108B2 (enExample)
BR (1) BR112021018496A2 (enExample)
CA (1) CA3134049A1 (enExample)
IL (1) IL286512B2 (enExample)
MX (2) MX2021011314A (enExample)
WO (1) WO2020191229A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020117855A1 (en) 2018-12-03 2020-06-11 Lyndra, Inc. Stomach simulating device
BR112021018496A2 (pt) 2019-03-20 2021-11-30 Lyndra Therapeutics Inc Cápsulas e revestimento de cápsula para formas de dosagem de residência gástrica
AU2020242062B2 (en) 2019-03-20 2025-12-11 Nortiva Bio, Inc. Coatings for gastric residence dosage forms
JP7847119B2 (ja) 2020-07-29 2026-04-16 ザ・セカント・グループ・エルエルシー 架橋ポリ(セバシン酸グリセロール)を含む構造を含む形状誘導型制御放出および保持
CN120091832A (zh) * 2022-08-03 2025-06-03 林德拉治疗公司 用于胃驻留系统的金属芯部

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706149D0 (en) 1997-03-25 1997-05-14 Scherer Corp R P Comestible capsules having flavoured coatings
WO2003051304A2 (en) 2001-12-15 2003-06-26 Spherics, Inc. Bioadhesive drug delivery system with enhanced gastric retention
DK1578350T3 (da) 2002-03-26 2009-08-10 Euro Celtique Sa Sammensætninger med gel-coating med depotvirkning
IL166183A0 (en) * 2005-01-06 2006-01-15 Yissum Res Dev Co Novel diagnostic and imaging techniques of the gi tract
KR20080005429A (ko) 2005-04-19 2008-01-11 알자 코포레이션 트라마돌 및 가바펜틴을 포함하는 물질의 배합물
WO2007002518A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Delayed release or extended-delayed release dosage forms of pramipexole
JP4948828B2 (ja) 2005-11-28 2012-06-06 森下仁丹株式会社 胃内浮遊滞留シームレスカプセルとその製造方法
CA2675230A1 (en) 2006-01-10 2008-07-26 Pipex, Inc. Pharmaceutical compositions and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases
EP2997953B1 (en) 2006-01-18 2018-12-26 Intec Pharma Ltd. Delivery device for oral intake of an agent
WO2007093999A1 (en) 2006-02-15 2007-08-23 Intec Pharma Ltd. A gastro-retentive system for the delivery of macromolecules
JP2012500230A (ja) 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
US8006033B2 (en) 2008-09-09 2011-08-23 Intel Corporation Systems, methods, and apparatuses for in-band data mask bit transmission
CA2745741A1 (en) 2008-12-04 2010-06-10 Intec Pharma Ltd. Zaleplon gastroretentive drug delivery system
US20100286628A1 (en) * 2009-05-07 2010-11-11 Rainbow Medical Ltd Gastric anchor
US8414559B2 (en) * 2009-05-07 2013-04-09 Rainbow Medical Ltd. Gastroretentive duodenal pill
EP2490677A2 (en) * 2009-10-19 2012-08-29 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
CA2825917C (en) 2011-02-14 2016-08-30 The Procter & Gamble Company Filmcoated solid dosage forms comprising honey in the coating
WO2014035639A1 (en) 2012-08-29 2014-03-06 Cardiac Pacemakers, Inc. Enhanced low friction coating for medical leads and methods of making
WO2015187746A1 (en) 2014-06-02 2015-12-10 Teva Pharmaceutical Industries Ltd. Expandable gastroretentive dosage form
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
NZ727659A (en) 2014-06-11 2021-12-24 Massachusetts Inst Technology Residence structures and related methods
WO2015195989A1 (en) 2014-06-20 2015-12-23 Banner Life Sciences Llc Enteric soft capsule compositions
EP3288604B1 (en) 2015-05-01 2021-11-17 Massachusetts Institute of Technology Triggerable shape memory induction devices
MX387092B (es) 2015-06-17 2025-03-19 Biogen Ma Inc Particulas de dimetilfumarato y composiciones farmaceuticas de estas.
US20190000768A1 (en) 2015-08-04 2019-01-03 Fuji Capsule Co., Ltd. Enteric capsule
US11576859B2 (en) 2015-10-23 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
WO2017100367A1 (en) 2015-12-08 2017-06-15 Lyndra, Inc. Geometric configurations for gastric residence systems
CN109310639A (zh) 2016-05-27 2019-02-05 林德拉有限公司 用于胃驻留系统的材料结构
JP2019532947A (ja) 2016-09-30 2019-11-14 リンドラ,インコーポレイティド アダマンタン系薬物の持続的送達のための胃内滞留システム
CN110035718B (zh) * 2016-12-02 2021-04-06 克雷西奥生物科技有限公司 胃内滞留系统
CA3066658A1 (en) 2017-06-09 2018-12-13 Lyndra, Inc. Gastric residence systems with release rate-modulating films
US11793751B2 (en) 2017-09-20 2023-10-24 Lyndra Therapeutics, Inc. Encapsulation of gastric residence systems
CN111587088A (zh) * 2017-11-28 2020-08-25 麻省理工学院 胃驻留电子装置
JP2021535090A (ja) 2018-08-15 2021-12-16 リンドラ セラピューティクス, インコーポレイティド 治療薬物の腸内送達のためのシステム
WO2020117855A1 (en) 2018-12-03 2020-06-11 Lyndra, Inc. Stomach simulating device
AU2020242062B2 (en) 2019-03-20 2025-12-11 Nortiva Bio, Inc. Coatings for gastric residence dosage forms
BR112021018496A2 (pt) 2019-03-20 2021-11-30 Lyndra Therapeutics Inc Cápsulas e revestimento de cápsula para formas de dosagem de residência gástrica
MX2022005494A (es) 2019-11-08 2022-08-11 Lyndra Therapeutics Inc Sistemas de residencia gastrica para la administracion de agentes activos.
JP2022553867A (ja) 2019-11-08 2022-12-26 リンドラ セラピューティクス, インコーポレイティド 胃内滞留を改善するフィラメントを有する胃内滞留システム
IL292848A (en) 2019-11-08 2022-07-01 Lyndra Therapeutics Inc Polymeric linkers for a gastric residence system
US20220387312A1 (en) 2019-11-08 2022-12-08 Lyndra Therapeutics, Inc. Gastric residence systems having arms with controlled stiffness for improved gastric residence
WO2021092486A1 (en) 2019-11-08 2021-05-14 Lyndra, Inc. Formulations for release-rate modulating films for gastric residence systems
US20240390270A1 (en) 2021-01-19 2024-11-28 Lyndra Therapeutics, Inc. Gastric residence systems for administration of risperidone
JP2024517829A (ja) 2021-05-05 2024-04-23 リンドラ セラピューティクス, インコーポレイティド メタドンを含む胃内滞留システム
WO2022236288A1 (en) 2021-05-05 2022-11-10 Lyndra Therapeutics, Inc. Gastric residence systems comprising buprenorphine and naloxone
AU2023209872A1 (en) 2022-01-19 2024-08-01 Nortiva Bio, Inc. Dosage forms for gastric retention
CN120091832A (zh) 2022-08-03 2025-06-03 林德拉治疗公司 用于胃驻留系统的金属芯部
JP2025531626A (ja) 2022-09-30 2025-09-22 リンドラ セラピューティクス, インコーポレイティド 胃内滞留システムを用いたリスペリドンの投与レジメン
US20240398701A1 (en) 2023-06-02 2024-12-05 Lyndra Therapeutics, Inc. Manufacturing methods for gastric residence systems

Also Published As

Publication number Publication date
CA3134049A1 (en) 2020-09-24
CN119033720A (zh) 2024-11-29
IL286512B1 (en) 2025-11-01
JP2022525926A (ja) 2022-05-20
EP3941445A1 (en) 2022-01-26
IL286512B2 (en) 2026-03-01
US20250332111A1 (en) 2025-10-30
AU2020240108B2 (en) 2025-12-04
EP3941445A4 (en) 2023-08-02
WO2020191229A1 (en) 2020-09-24
BR112021018496A2 (pt) 2021-11-30
US12447130B2 (en) 2025-10-21
IL286512A (en) 2021-10-31
CN113966216A (zh) 2022-01-21
AU2020240108A1 (en) 2021-11-11
US20220160642A1 (en) 2022-05-26
MX2025012985A (es) 2025-12-01
JP2025066761A (ja) 2025-04-23

Similar Documents

Publication Publication Date Title
MX2021011314A (es) Capsulas y recubrimientos de capsulas para formas de dosificacion de residencia gastrica.
CY1121301T1 (el) Πολλαπλης φασης καψουλες μαλακης πηκτης, συσκευη και μεθοδος αυτων
Poce et al. SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development
IL262581A (en) The manufacturing methods, compositions, and medical applications of orally administered cannabis pharmaceuticals
CY1124052T1 (el) Δισκιο διασπειρομενο στο στομα περιεχον οιστετρολη
AR048331A1 (es) Sistema de administracion de farmacos con retencion gastrica
BR112017001032A2 (pt) revestimento para cateter expansível intraluminal que fornece transferência de contato de micro-reservatórios de fármacos
EA201791702A1 (ru) Терапевтические средства на основе гликанов и связанные с ними способы
EA201792290A1 (ru) Таблетка, содержащая рибоциклиб
MX2021011310A (es) Recubrimientos para formas de dosificacion de residencia gastrica.
CO2017002682A2 (es) Composiciones y métodos para recubrimientos cannabinoides para uso en la entrega de fármacos
RU2018126158A (ru) Применение триацетил-3-гидроксифениладенозина для получения фармацевтического лекарственного средства для предупреждения или лечения неалкогольной жировой болезни печени
Maldonado et al. Update on Emerging Infections: news from the Centers for Disease Control and Prevention. Update to the CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections
CY1125250T1 (el) Εντερικο επικαλυμμενο χορηγουμενο απο το στομα φαρμακευτικο παρασκευασμα που περιλαμβανει φουμαρικο διμεθυλεστερα
CO2021008688A2 (es) Fórmula de entrega de medicamentos colónicos
EA201991667A1 (ru) Экстренное лечение постоперационной тошноты и рвоты
Teschke et al. Herbal hepatotoxicity--an update on traditional Chinese medicine preparations; authors' reply
CY1125503T1 (el) Διαδικασια για στερεα σκευασματα μεσαλαζινης
Sonawane et al. An Innovative Approach
PE20171340A1 (es) Composicion farmaceutica para el tratamiento de enfermedades gastrointestinales
CL2017000026A1 (es) Formas de dosificación farmacéutica
WO2018193337A3 (en) POLYMER-BASED FORMULATION FOR THE RELEASE OF MEDICINES AND BIOACTIVE PRODUCTS AT SPECIFIC GIT SITES
UA111998U (uk) Застосування декаметоксину як фармацевтично активної речовини для лікування захворювань шлунково-кишкового тракту та кишкових інфекцій перорально
TH147933A (th) สูตรผสมยาชนิดปลดปล่อยแบบชะลอ
IT201900025345A1 (it) Dispositivo e sistema medicale per la somministrazione di una sostanza medicale o per il dosaggio di fluidi corporei, e relativo metodo di realizzazione